VE303
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for VE303, covering 2023-07-03 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: VE303 for Prevention of Recurrent Clostridioides Difficile Infection [Phase 3]